About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Research: Promise for Mood and Anxiety Disorders Shown by Glutamatergic Agents

by Rukmani Krishna on October 9, 2013 at 12:45 AM
Font : A-A+

 Research: Promise for Mood and Anxiety Disorders Shown by Glutamatergic Agents

New research presented at the 26th ECNP Congress suggests that glutamergic agents may one day be used as a novel treatment for mood and anxiety disorders.

"Our results suggest the glutamatergic system is a truly viable target for antidepressant Profug development," says Professor Gerard Sanacora, from the Yale School of Medicine, Connecticut, US.

Advertisement

In his talk, Professor Sanacora detailed how he and his team have used animal models to help understand how stress and other mechanisms that can disrupt glutamatergic function can lead to molecular, cellular and behavioural changes in the brain that are characteristic of depression.

He also presented results from a completed phase II trial with a unique non-selective NMDA receptor antagonist.

"We found that drugs that can target glutamate transmission, either by altering release, uptake or receptor activation can prevent or attenuate the cellular and behavioural changes seen in mood disorders," he explains.
Advertisement

In humans, the NMDA receptor antagonist showed a surprisingly rapid antidepressant effect. Importantly, the trial demonstrated the potential ability to dissociate the perceptual and cognitive effects of the NMDA receptor antagonists from the antidepressant effects.

His results also suggest the antidepressant effects can be extended for several weeks with repeated infusions.

In rodent models, the team demonstrated that stress has a major impact on the function of glutamate neurotransmission - especially glutamate clearance through glial cells - that appears to be related to behavioural changes.

Professor Sanacora presented a series of preclinical and clinical studies indicating that a novel class of drugs that target components of the glutamatergic neurotransmitter system may produce rapid and robust antidepressant effects.

"There is a rapidly expanding literature suggesting the glutamatergic neurotransmitter system is altered in the brains of individuals suffering with mood disorders," explains Professor Sanacora.

"There is also increasing evidence suggesting stress may disrupt normal glutamtergic function in the brain and may be a mechanism contributing to the pathogenesis of several stress-related neuropsychiatric disorders," he adds.

Their research, due to be published in the journal Molecular Psychiatry adds to this body of evidence.

"First and foremost, our findings suggest the glutamatergic system is a truly viable target for antidepressant drug development," concludes Professor Sanacora.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
Toothache
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Anxiety Disorder Agoraphobia Asperger´s Syndrome Stress Relief Through Alternative Medicine Hyperventilation Bereavement Post Traumatic Stress Disorder Xenophobia Is Your Man Moody? Tourette Syndrome 

Recommended Reading
Circadian Rhythm Sleep Disorders
Circadian rhythm (also known as sleep/wake cycle or the body clock) is a biological process that ......
Phobias
A phobia is an irrational and exaggerated fear of an object or a situation that in reality, poses .....
Anxiety - Symptom Evaluation
Anxiety is a state of mind where a person experiences fear, uneasiness, tension, irritability or ......
Kava Plant may Offer a Natural Remedy for Anxiety Disorders
The South Pacific kava plant is found to provide a natural remedy for treatment of anxiety, ......
Agoraphobia
Agoraphobia is an anxiety disorder characterised by the patient avoiding spaces, crowds, or ......
Anxiety Disorder
Anxiety disorder involves excessive worry about actual circumstances, events or conflicts. Anyone ca...
Asperger´s Syndrome
Asperger’s Syndrome or (AS) is a neurological condition marked by delay in the development of motor ...
Bereavement
Bereavement refers to grief, pain and sadness following the loss of a loved one, especially during t...
Hyperventilation
Hyperventilation occurs when a person breathes in excess to the body’s requirement....
Is Your Man Moody?
Women get confused by the behavior of men in their lives. It is time they realize that men too have ...
Post Traumatic Stress Disorder
Post Traumatic Stress Disorder (PTSD), is a mental condition triggered by a traumatic event. PTSD tr...
Tourette Syndrome
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and s...
Xenophobia
Xenophobia can be studied from two different perspectives. First as a medical condition ‘phobia’ sec...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use